Tyrosine Kinase Receptor B, phospho Ser478/479 (TrkB, pS478/479), Rabbit Polyclonal Antibody

As low as US$317.00
Only %1 left
Catalog Number
R-1718

    Product Info

  • Product Name Tyrosine Kinase Receptor B, phospho Ser478/479 (TrkB, pS478/479), Rabbit Polyclonal Antibody
  • Product Description google
    Rabbit anti-Tyrosine Kinase Receptor B, phospho Ser478/479 (TrkB, pS478/479) Polyclonal Antibody (Unconjugated), suitable for WB, IHC-Frozen.
  • Alternative Names GP145-TrkB; Neurotrophic tyrosine kinase receptor type 2; TrkB tyrosine kinase; Tropomyosin-related kinase B; pTrkB; phosphoTrkB; phospho-TrkB
  • Application(s) IHC-Frozen, WB
  • Antibody Host Rabbit
  • Antibody Type Polyclonal
  • Specificity Human TrkB (pS478). Antibody has been shown to be specific for TrkB phosphorylated on serine 478 by phospho-peptide absorption dot blots, and on cell lysates from cell lines induced with retinoic acid and BDNF. Antibody detects a clear band in retinoic acid (RA) and BDNF-treated NSC34 cell lysates at ~120 kDa only, demonstrating that the phosphorylated TrkB receptor is being detected. Additional non-specific bands at lower molecular weight may be observed in lysates and homogenates with the antibody and these bands have not been characterized.
  • Species Reactivity Chicken (Predicted), Human, Mouse, Rat
  • Immunogen Description Synthetic peptide immunogen, SNDDDSA[pS]PLHHIS
  • Conjugate Unconjugated
  • Purity Description Affinity purified, and absorbed.
  • Regulatory Status For research use only.

    Specifications

  • Product Description
    Rabbit anti-Tyrosine Kinase Receptor B, phospho Ser478/479 (TrkB, pS478/479) Polyclonal Antibody (Unconjugated), suitable for WB, IHC-Frozen.
  • Related Products TrkB (pS478) Positive Control Cell Lysate (Mouse NSC-34)
    Tyrosine Kinase Receptor B (TrkB), Mouse Monoclonal Antibody
    Tyrosine Kinase Receptor B, phospho Tyr816/Y817 (TrkB, pY816/817), Rabbit Polyclonal Antibody
    Tyrosine Kinase Receptor B (TrkB), Rabbit Polyclonal Antibody
  • Application(s) IHC-Frozen, WB
  • Application Details Western Blotting (0.5 - 2 µg/mL). Cell lysates or membrane preparations prepared from isolated brain or spinal cord tissues are recommended. This antibody works on skim milk blocked membranes, however, best results are obtained with a equal mixture of 2.5% skim milk / 2.5% highly purified BSA as blocking reagent and antibody diluent.
    Immunohistochemistry (1 - 5 µg/mL). Antibody has been shown to work on PFA fixed, frozen sections. TBS is preferred for buffer preparation.
    Other applications have not been tested. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
  • Product Validation Antibody is specific for TrkB serine phosphorylation at amino acid 478/479 (rodents/human). Lambda-phosphatase treatment obliterates positive staining.
  • Target Tyrosine Kinase Receptor B, phospho Ser478/479 (TrkB, pS478/479)
  • Specificity Human TrkB (pS478). Antibody has been shown to be specific for TrkB phosphorylated on serine 478 by phospho-peptide absorption dot blots, and on cell lysates from cell lines induced with retinoic acid and BDNF. Antibody detects a clear band in retinoic acid (RA) and BDNF-treated NSC34 cell lysates at ~120 kDa only, demonstrating that the phosphorylated TrkB receptor is being detected. Additional non-specific bands at lower molecular weight may be observed in lysates and homogenates with the antibody and these bands have not been characterized.
  • Target Host Species Human
  • Species Reactivity Chicken (Predicted), Human, Mouse, Rat
  • Antibody Host Rabbit
  • Antibody Type Polyclonal
  • Antibody Isotype IgG
  • Conjugate Unconjugated
  • Immunogen Description Synthetic peptide immunogen, SNDDDSA[pS]PLHHIS
  • Immunogen Length 14 amino acids
  • Sequence SNDDDSA[pS]PLHHIS
  • Epitope Intracellular (cytosolic)
  • Positive Control Retinoic acid- and BDNF-treated NSC34 cells
  • Isoform Information Detects full-length TrkB phosphorylated at amino acid S479 in humans (S478 in mouse and rat).
  • Purity Description Affinity purified, and absorbed.
  • Physical State Solid
  • Format Lyophilized.
  • Formulation

    Lyophilized from 1 x PBS, pH 7.2-7.6, with 0.1% trehalose

  • Reconstitution Instructions Spin vial briefly before opening. Reconstitute in 50 µL sterile-filtered, ultrapure water. Centrifuge to remove any insoluble material. Final buffer contains no preservatives.
  • Storage Instructions Store lyophilized antibody at 2-8°C. After reconstitution divide into aliquots and store at -20°C for long-term storage. Store at 2-8°C short-term (up to 4 weeks) with an appropriate antibacterial agent. Avoid repetitive freeze/thaw cycles.
  • Batch Number Please see item label.
  • Expiration Date 12 months after date of receipt (unopened vial).
  • Alternative Names GP145-TrkB; Neurotrophic tyrosine kinase receptor type 2; TrkB tyrosine kinase; Tropomyosin-related kinase B; pTrkB; phosphoTrkB; phospho-TrkB
  • Uniprot Number Q16620
  • Uniprot Number/Name Q16620 (NTRK2_HUMAN)
  • Cellular Localization Cell membrane
  • Scientific Background The protein named TrkB (also named Neurotrophic tyrosine kinase receptor type 2 (NTRK2), GP145-TrkB or Tropomyosin-related kinase B is a receptor tyrosine kinase involved in the development and the maturation of the central and the peripheral nervous systems and is important in the regulation of neuron survival, proliferation, migration, differentiation, and synapse formation and plasticity. TrkB may also play a role in neutrophin-dependent calcium signaling in glial cells and mediate communication between neurons and glia. TrkB is the primary receptor for BDNF (brain-derived neurotrophic factor. TrkB also binds NT4 and NT3 but less efficiently. Upon ligand-binding, the receptor undergoes homodimerization, autophosphorylation and activation. TrkB activation recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that each regulate distinct overlapping signaling cascades within cells. Through SHC1, FRS2, SH2B1, SH2B2, these activate the GRB2-Ras-MAPK cascade that regulates, for instance, neuronal differentiation including neurite outgrowth. These same effectors also control the Ras-PI3 kinase-AKT1 signaling cascade that mainly regulates growth and survival. TrkB, via activation of PLCG1 and the downstream protein kinase C-regulated pathways, also controls synaptic plasticity, and thus plays a role in learning and memory by regulating both short term synaptic function and long-term potentiation. PLCG1 also leads to NF-Kappa-B activation and the transcription of genes involved in cell survival. One such consequence is that PLCG1 activation via TrkB is able to suppress anoikis, the apoptosis resulting from loss of cell-matrix interactions. (Reference: www.uniprot.org)
  • Shipping Temperature 25°C (ambient)
  • UNSPSC CODE 41116161
  • Regulatory Status For research use only.

    Images, Protocols & SDS

  • Western blot of TrkB (pS478) in mouse NSC34 cell lysates (20 µg/lane). TrkB receptor expression was induced by treating NSC34 cells with retinoic acid. TrkB receptor phosphorylation was triggered by adding BDNF protein to the culture medium, while control cells were left untreated. R-1718-50 (1 µg/mL) detects a band at about ~120 kDa in BDNF-treated cells only, corresponding to full-length TrkB protein phosphorylated at amino acid residue serine 478. Lower molecular weight bands are not characterized, but are likely unrelated to phosphorylation due to equal band intensities in BDNF-treated and untreated cells. SDS-PAGE: denatured and reduced; Transfer: Tris-Glycine buffer; Membrane: nitrocellulose (0.45 µm); Blocking: 5% skim milk in TBST, 1 hour at RT; Primary antibody: overnight at 2-8°C; Secondary antibody: anti-rabbit-HRP (1/6000) 2 hours at RT; Detection: Chemiluminiscence.

  • Immunohistochemical analysis of TrkB (pS478) expression in mouse cerebral cortex, including corpus callosum, using rabbit antibody R-1718-50. Mice were perfused (4% PFA), post-fixed followed by cryopreservation with 30% sucrose and frozen on isopentane. Saggittal cryostat sections were blocked with 10% NDS, 1% BSA in 1x TBS with 0.3% Triton-X100 (15 min, room temperature). Sections were incubated with primary antibody R-1718-50 (1:200, red) at 2-8°C overnight, with subsequent application of donkey anti-rabbit-Alexa594 secondary antibody (1:400, 2 hour incubation at room temperature). Sections were co-labelled with goat anti-PDGFRa (green) as positive control. Scale bar = 100 µm. Images courtesy of Dr Jessica Fletcher, University of Melbourne, Australia.


    Western blot analysis of TrkB (pS478) in mouse NSC34 RIPA cell lysates and mouse cortex homogenate (20 μg protein/lane). Cells were grown in proliferation medium in presence and absence of Retinoic Acid (RA, 1 μM) for 5 days. Cells were then serum-starved for 4 hours and treated with 50 ng/mL BDNF for 5-30 min. Control experiment: Mouse cortex RIPA homogenate. SDS-PAGE: 4-12%, reducing conditions; Transfer: Towbin’s Tris-Glycine buffer, PVDF membrane (0.45 μm); Blocking: 5% skim milk in TBST, 1 hour at RT; Primary antibody: 1 μg/mL, overnight at 2-8°C; Secondary antibody: anti-rabbit-HRP (1/10,000) 2 hour at RT; Detection: Chemiluminiscence.

    R-1718-50 reveals a single band at ~120 kDa demonstrating detection of pTrkB (S478). RA and BDNF treatment increase band intensity. The membrane was then stripped and re-probed with rabbit antibody to GAPDH (R-1701-100, 1:10,000, following WB procedure as above) to assess well-to-well loading consistency. Densitometric band analysis for GAPDH and pTrkB (S478) shows equal loading amounts per well, confirming increase in TrkB (S478) phosphorylation upon treatment.

    In mouse cortex, pTrkB (S478) is detected at ~120 kDa, with additional uncharacterized lower molecular weight bands.


    Western blot analysis of TrkB pS478 expression in NSC34 RIPA cell lysates (10 μg protein/lane) and mouse cortex (30 μg protein/lane) with and without lambda-phosphatase treatment. Cells were grown in proliferation medium in presence and absence of Retinoic Acid (RA, 1 μM) for 5 days. Cells were then serum-starved for 4 hours and treated with 50 ng/mL BDNF for 30 min. SDS-PAGE: 4-12%, reducing conditions; Transfer: Towbin’s Tris-Glycine buffer, PVDF membrane (0.45 μm); Blocking: 5% skim milk in TBST, 1 hour at RT; Primary antibody: 1 μg/mL, overnight at 2-8°C; Secondary antibody: anti-rabbit-HRP (1/10,000) 2 hour at RT; Detection: Chemiluminiscence.

    R-1718-50 detects one single strong band at ~120 kDa in NSC34 cell lysates, consistent with pTrkB (S478) expression. Lambda-phosphatase treatment of the membrane obliterates pTrkB (S478) detection, confirming that the detected band is indeed pTrkB (S478). In mouse cortex, lambda-phosphatase treatment causes the disappearance of the pTrkB (S478) band at ~120 kDa, while band intensity for the other 2 uncharacterized lower molecular weight bands remains largely unchanged.


    Comparison of blocking buffers for Western blot analysis of TrkB pS478 expression in NSC34 RIPA cell lysates (10 μg protein/lane) and mouse cortex (30 μg protein/lane) using rabbit antibody R-1718-50. SDS-PAGE: 4-12%, reducing conditions; Transfer: Towbin’s Tris-Glycine buffer, PVDF membrane (0.45 μm); Blocking Buffers tested: 5% skim milk in TBST, 5% BSA in TBST, 2.5%/2.5% skim milk/BSA in TBST, 1 hour at RT; Primary antibody: 1 μg/mL, overnight at 2-8°C; Secondary antibody: anti-rabbit-HRP (1/10,000) 1.5 hours at RT; Detection: Chemiluminiscence.

    Lowest background is achieved with 5% skim milk blocking buffer. While skim milk appears to slightly reduce signal intensity, it provides cleanest blots. To achieve highest sensitivity with acceptable background, a mixture of skim milk and BSA (each 2.5%) appears to provide the best compromise as blocking buffer for R-1718-50 antibody (TrkB pS478).


    Western blot analysis of TrkB pS478 expression in Retinoic Acid (RA)- and BDNF-treated (50 ng/mL BDNF, 15 minutes) NSC34 cells, and untreated rodent tissue homogenates. Samples were lysed with RIPA buffer and 10 μg loaded for cell lysates and 40 μg for tissue homogenates. SDS-PAGE: 4-12%, reducing conditions; Transfer: Towbin’s Tris-Glycine buffer, PVDF membrane (0.45 μm); Blocking buffer and antibody diluent: Mixture of 2.5% skim milk and 2.5% BSA in TBST, blocking 1 hour at RT; Primary antibody: 1 μg/mL, overnight at 2-8°C; Secondary antibody: anti-rabbit-HRP (1/10,000) 2.5 hours at RT; Detection: Chemiluminiscence.

    Tissue samples show expression of TrkB phosphorylated at serine residue 478. The RA/BDNF-treated cell lysate serves as positive control supporting the assignment of the phosphorylated TrkB band. Additional bands are observed in tissue samples that have not yet been characterized.

    Citations & References

  • Specific References Turnbull MT et al. (2018), Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion. Front Mol Neurosci. 2018 Feb 22;11:51. Species: Mouse; Application: WB, hippocampal lysates.

    Matusica D et al. (2016), Inhibition of motor neuron death in vitro and in vivo by a p75 neurotrophin receptor intracellular domain fragment. J Cell Sci. 2016 Feb 1;129(3):517-30. doi: 10.1242/jcs.173864. Epub 2015 Oct 26. Species: Mouse; Application: WB, spinal cord lysates.

  • General References Lai K-O. et al. (2012), Nature Neuroscience 15, 1506-1515, doi:10.1038/nn.3237.

    Zhao L. et al. (2009), Journal of Cell Science 122, 3123-3136, doi: 10.1242/jcs.047712.